C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/14 (2006.01) A61K 31/517 (2006.01) A61P 35/00 (2006.01) C07D 239/94 (2006.01) C07D 401/12 (2006.01) C07D 413/12 (2006.01) C07D 417/14 (2006.01) C07D 498/02 (2006.01)
Patent
CA 2535614
This invention provides quinazoline analogs of Formula (I): where A is bonded to at least one of the carbons at the 5, 6, 7 or 8 position of the bicyclic ring, and the ring is substituted by up to two independent R3 groups. The invention also includes methods of using compounds of Formula (I) as type I receptor tyrosine kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
L'invention concerne des analogues de quinazoline de la formule I, dans laquelle A est lié à au moins un des carbones à la position 5, 6, 7 ou 8 du noyau bicyclique, ledit noyau étant substitué par au maximum deux groupes R<3> indépendants. L'invention concerne également des procédés d'utilisation de composés de la formule I comme inhibiteurs du récepteur de la tyrosine kinase et dans le traitement de maladies hyperprolifératives telles que le cancer.
Buckmelter Alexandre
Lyssikatos Joseph
Topalov George
Wallace Eli
Zhao Qian
Array Biopharma Inc.
Robic
LandOfFree
Quinazoline analogs as receptor tyrosine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinazoline analogs as receptor tyrosine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinazoline analogs as receptor tyrosine kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1560596